Buy & Sell Phillips 66 (PSX) – Phillips 66 Price Today
Aura AI Summary
Key Stats
- $69.71BMarket Cap
- EnergySector
- -17.28%3M Drawdown
- $91.69BEnterprise Value
- 2.92%Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 61 daysTypical Hold Time
Phillips 66 (PSX) is currently valued at a market capitalization of $69.71B, with an enterprise value of $91.69B. Over the past 52 weeks, Phillips 66 has traded between a low of $112.23 and a high of $188.28, highlighting its annual price range. Over the past three months, Phillips 66 has recorded a drawdown of -17.28%, reflecting recent price volatility. Phillips 66 offers a dividend yield of 2.92%, with the most recent dividend of $1.27 paid on 18 May 26. On average, investors hold Phillips 66 for approximately 61 days, indicating typical investor behavior on the platform.
About Phillips 66
Phillips 66 is an independent refiner with 12 refineries that have a total crude throughput capacity of 2.0 million barrels per day, or mmb/d, after converting its 255 mb/d Alliance refinery to a terminal. The midstream segment comprises extensive transportation and NGL processing assets. It also includes its DCP Midstream joint venture, which holds 45 natural gas processing facilities, 11 NGL fractionation plants, and a natural gas pipeline system with 58,000 miles of pipeline. Its CPChem chemical joint venture operates facilities in the United States and the Middle East and primarily produces olefins and polyolefins.
Most Recent News
Virtual assistants in retirement plans show wide performance gaps; Fidelity and Voya lead with top AI features.
Corporate Insight's report reveals significant differences in virtual assistant performance across eight retirement plan recordkeepers. Fidelity and Voya received top marks for delivering real-time account data, strong natural language processing, an...

Broadcom launches new 5G and Wi-Fi 8 platform with Samsung, expands AI and broadband tech.
Broadcom announced a partnership with Samsung to release the first integrated 5G and Wi-Fi 8 fixed wireless access platform, aiming to improve broadband reliability and efficiency. The company also introduced new Wi-Fi 8 chips for home routers and pa...

Glioblastoma multiforme market to grow 13.2% CAGR by 2036 with new therapies advancing.
The glioblastoma multiforme market is projected to grow at a 13.2% CAGR from 2026 to 2036, driven by promising late-stage therapies from companies like Avita Biomedical and Laminar Pharma. The market size was $900 million in 2025, with the US as the ...
